Published on in Vol 5, No 12 (2017): December

Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment

Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment

Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment

Journals

  1. Hong Y, Hossain M, Chou W. Digital interventions to facilitate patient‐provider communication in cancer care: A systematic review. Psycho-Oncology 2020;29(4):591 View
  2. Cannella L, Efficace F, Giesinger J. How should we assess patient-reported outcomes in the onco-hematology clinic?. Current Opinion in Supportive & Palliative Care 2018;12(4):522 View
  3. Skrabal Ross X, Gunn K, Patterson P, Olver I. Mobile-Based Oral Chemotherapy Adherence–Enhancing Interventions: Scoping Review. JMIR mHealth and uHealth 2018;6(12):e11724 View
  4. Russell L, Pascoe M, Seymour J, Aranda S, Butow P, Gough K, Schofield P. The trials and tribulations of conducting an m-health pilot randomized controlled trial to improve oral cancer therapy adherence: recommendations for future multisite, non-drug clinical trials. BMC Research Notes 2019;12(1) View
  5. Crysandt M. Therapieadhärenz und Therapieabsetzen bei Patienten mit CML. InFo Hämatologie + Onkologie 2020;23(5):10 View
  6. Given C, Given B, Sikorskii A, Krauss J, Vachon E. Challenges to the design and testing supportive interventions for cancer patients treated with oral oncolytic agents. Supportive Care in Cancer 2018;26(12):3975 View
  7. Crawford S, Boyd A, Nayak A, Venepalli N, Cuellar S, Wirth S, Hsu G. Patient-centered design in developing a mobile application for oral anticancer medications. Journal of the American Pharmacists Association 2019;59(2):S86 View
  8. Zackon A, Ayers A, Yeager K, Somma M, Friedberg J, Flowers C, Nastoupil L. Maximizing the effectiveness of oral therapies in lymphoid cancers: research gaps and unmet needs. Leukemia & Lymphoma 2019;60(10):2356 View
  9. Rosenberg S, Petrie K, Stanton A, Ngo L, Finnerty E, Partridge A. Interventions to Enhance Adherence to Oral Antineoplastic Agents: A Scoping Review. JNCI: Journal of the National Cancer Institute 2020;112(5):443 View
  10. Marshall V, Given B. Satisfaction With an Interactive Voice Response System and Symptom Management Toolkit Intervention to Improve Adherence in Patients Prescribed an Oral Anticancer Agent. Oncology Nursing Forum 2020;47(6):637 View
  11. Gambalunga F, Iacorossi L, Notarnicola I, Serra V, Piredda M, De Marinis M. Mobile Health in Adherence to Oral Anticancer Drugs. CIN: Computers, Informatics, Nursing 2021;39(1):17 View
  12. Karim J, Talhouk A. Person-Generated Health Data in Women’s Health: Protocol for a Scoping Review. JMIR Research Protocols 2021;10(5):e26110 View
  13. Karaaslan-Eşer A, Ayaz-Alkaya S. The effect of a mobile application on treatment adherence and symptom management in patients using oral anticancer agents: A randomized controlled trial. European Journal of Oncology Nursing 2021;52:101969 View
  14. Heiney S, Sorrell M, Sheng J, Adams S, Nelson K, Nguyen L, Edwards A, Wickersham K. Interventions to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. American Journal of Clinical Oncology 2021;44(6):291 View